Japan Ministry of Health expert delegation approved the drug “Baricitinib” for Covid-19 treatment – Health News

The expert delegation of the Ministry of Health, Labor and Welfare of Japan approved the use of rheumatoid arthritis drug “Baricitinib” in the treatment of the new type of corona virus (Covid-19). According to the Kyodo agency, the rheumatic arthritis drug “Baricitinib”, produced by the US Eli Lily, was approved by the expert health delegation under the ministry. The company applied to the ministry for approval of the drug in December. The ministry is expected…

"Japan Ministry of Health expert delegation approved the drug “Baricitinib” for Covid-19 treatment – Health News"